Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
20.15
-0.88 (-4.18%)
At close: Jul 19, 2024, 4:30 PM
20.19
+0.04 (0.20%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Contineum Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CTNM stock have an average target of 28, with a low estimate of 25 and a high estimate of 30. The average target predicts an increase of 38.96% from the current stock price of 20.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 30, 2024.
Analyst Ratings
The average analyst rating for CTNM stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +43.92% | Apr 30, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $30 | Buy | Initiates | $30 | +48.88% | Apr 30, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +24.07% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
n/a
from 50.00M
Revenue Next Year
10.20M
EPS This Year
-1.87
from 0.08
EPS Next Year
-1.60
from -1.87
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 31.5M | n/a |
| Avg | n/a | 10.2M | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.64 | -0.79 | -2.51 |
| Avg | -1.87 | -1.60 | -2.83 |
| Low | -1.99 | -1.84 | -2.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.